Carrolee Barlow's most recent trade in Supernus Pharmaceuticals Inc was a trade of 5,369 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 22, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 22,570 (0%) | 0% | 0 | Common Stock | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 0 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,886 | 17,201 (0%) | 0% | 0 | Common Stock | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
Supernus Pharmaceuticals Inc | Barlow Carrolee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 6,293 | 6,293 | - | - | Director Stock Option (Right to Buy) | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,886 | 3,886 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 0 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,882 | 13,315 (0%) | 0% | 0 | Common Stock | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 6,847 | 6,847 | - | - | Director Stock Option (Right to Buy) | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,882 | 3,882 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 9,433 (0%) | 0% | 0 | Common Stock | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Feb 2022 | 4,222 | 0 | - | - | Restricted Stock Units | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 7,365 | 7,365 | - | - | Director Stock Option (Right to Buy) | |
Supernus Pharmaceuticals Inc | Carrolee Barlow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 4,222 | 4,222 | - | - | Restricted Stock Units |